Fig. 4

Expression levels of apoptosis-associated proteins in lucidadiol-treated B16 melanoma cells. A Representative blots of Bax expression levels in B16 melanoma cells treated with lucidadiol (0 and 15 µM) for 0 and 48 h. The graph represents the Bax expression level with/without lucidadiol treatment at 48 h. B Representative blots of p53, PARP, and caspase-3 expression levels in B16 melanoma cells treated with lucidadiol (0 and 15 µM) for 0 and 48 h. The graph represents p53, PARP, and caspase-3 expression levels in cells with/without lucidadiol treatment at 48 h. The data are presented as the mean ± SD. *p < 0.05 when compared with the control group